Specifically, we propose that cancer induction of cachexiainvolves: i) decreased expression of PGC-1ß, which normally inhibits FoXOs; and ii)attenuated AKT activity, which both enable activation of FoXO3α and upregulate theexpression of atrogenes, which then facilitate muscle degradation. The gene discussed is PPARGC1A; the disease is cancer.